Current technical overviews of sentinel lymph node biopsy for breast cancer.
Sentinel lymph node biopsy (SLNB) is based on the hypothesis that the sentinel lymph node (SLN) reflects the lymph-node status and a negative SLN might allow complete axillary lymph node dissection (ALND) to be avoided. Although the survival outcome is still unknown, this technique has already become a standard of care for breast cancer patients. However, it is still important to discuss current techniques and some controversies. This article reviews these issues for a variety of SLNB techniques.
Sato
Kazuhiko
K
Department of Surgery, Self-Defense Forces Central Hospital, Setagaya, Tokyo, 154-8532, Japan. kazsato@lake.ocn.ne.jp
D001943:Breast Neoplasms / Q000473:pathology*; D002986:Clinical Trials as Topic; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D011379:Prognosis; D021701:Sentinel Lymph Node Biopsy